Results for tag: "Invasive Fungal Infection Drug"

The Invasive Fungal Infection Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat fungal infections that have spread beyond the skin and mucous membranes and into the bloodstream or organs. These drugs are used to treat a variety of fungal infections, including candidiasis, aspergillosis, and cryptococcosis. The drugs used to treat these infections are antifungal agents, such as azoles, echinocandins, and polyenes. These drugs are used to treat both acute and chronic fungal infections, and are often used in combination with other drugs. The Invasive Fungal Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Novartis, AstraZeneca, and GlaxoSmithKline. Other companies in the market include Sanofi, Johnson & Johnson, Bayer, and Allergan. Show Less Read more